All Diagnostic device articles
-
BusinessSecond Theranos executive convicted of fraud
Blood testing startup president Ramesh ‘Sunny’ Balwani defrauded both investors and patients
-
ResearchMolecular pendulum sensors could track and monitor disease
DNA–antibody probes can detect specific proteins inside a live subject
-
NewsHand-powered centrifuge setup can diagnose Covid-19 for just a dollar a test
$5 centrifuge based on children’s toy part of raft of cheap technologies that can detect the virus in saliva in remote locations
-
BusinessExpanding precision medicine beyond cancer
Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune
-
BusinessTroubled Theranos abandons clinical testing
Seeking to salvage some value, once-admired blood analysis firm lays off 40% of staff
-
BusinessMedical devices consolidation continues
Abbott to buy Alere for $5.8bn to augment its point-of-care diagnostics business
-
BusinessUS regulator reprimands Cepheid for norovirus diagnosis tool quality
Diagnostics firm has 15 days to respond to violations laid out by regulator
-
ResearchIndividual microRNA molecules detected with a single microbead
Beady-eyed bioassay can identify important nucleotides on the single molecule level
-
ResearchCancer biomarker counted up with the naked eye
Precise levels of nucleic acids linked to cancer can be detected by the naked eye
-
Business
Opko deepens diagnostics with $1.5bn lab buyout
Taking over clinical diagnostics service provider BioReference Laboratories gives Opko a bigger avenue to distribute and market its diagnostic tests
-
Business23andMe jumps into drug R&D
Gene profiling firm aims to capitalise on its databank of genetic information to discover new drugs
-
BusinessUS opens up home DNA screening
FDA approves single disease genetic test and clears pathway for similar devices
-
Business
Labcorp to buy Covance and enter contract research
Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal’s value
-
Business
Illumina targets cancer diagnostics
Sequencing will improve tests and speed up clinical trials processes for big pharma partners
-
NewsUS supreme court rules genes can't be patented
Breast cancer test company at centre of case can still rely on patents on non-naturally occurring DNA
-
Business
Two new ‘personalised’ cancer drugs approved
Suitable patients for GSK’s melanoma treatments must be identified using an accompanying genetic test